Perioperative Nesiritide Versus Milrinone in High-Risk Coronary Artery Bypass Graft Patients

Background: Patients with left-ventricular dysfunction have an increased risk of developing heart failure after coronary artery bypass graft (CABG) surgery. Therapies to maintain cardiac output in such patients warrant investigation. Nesiritide is unique among intravenous medications used to manage...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of pharmacotherapy 2007-03, Vol.41 (3), p.427-432
Hauptverfasser:	Brackbill, Marcia L, Stam, M Denton, Schuller-Williams, Rebecca V, Dhavle, Ajit A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences Cardiac Output, Low - epidemiology Cardiac Output, Low - prevention & control Cardiology. Vascular system Cardiotonic Agents - therapeutic use Coronary Artery Bypass Coronary heart disease Female Heart Hospitals, Voluntary Humans Intensive Care Units - statistics & numerical data Length of Stay - statistics & numerical data Male Medical sciences Middle Aged Milrinone - therapeutic use Natriuretic Agents - therapeutic use Natriuretic Peptide, Brain - therapeutic use Perioperative Care Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!